Apimeds Pharmaceuticals US Inc
APUS
View Detailed Chart
1.620USD
+0.200+13.70%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
20.37MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+13.70%
5 Days
-12.43%
1 Month
-9.50%
6 Months
-4.71%
Year to Date
-1.22%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Apimeds Pharmaceuticals US Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Apimeds Pharmaceuticals US Inc Info
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Ticker SymbolAPUS
CompanyApimeds Pharmaceuticals US Inc
CEOMenon (Vin)
Websitehttps://www.apimedsus.com/
Related Instruments
+3.66%
+3.17%
+0.93%
+1.99%
+1.78%
+1.60%
-0.95%
+4.49%
+2.10%
+10.00%
+2.72%
+4.15%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
67610.210
-2359.920 (-3.37%)
282.580
+22.390 (+8.61%)
2000.410
-51.320 (-2.50%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
